Mammalian target of rapamycin
Combination of everolimus and exemestane improves survival for women with metastatic breast cancer
San Antonio, TX – In an international Phase III randomized study, everolimus, when combined with the hormonal therapy exemestane, has been shown to dramatically improve progressionSan Antonio, TX – In an international Phase III randomized study, everol…